American Journal of Infectious Diseases and Microbiology
To investigate the efficacy of herbal, dietary, complementary, and natural therapies in prevention and treatment of viral infection. Respiratory viruses are a major cause of influenza-like illness (ILI) symptoms in children and adults, leading to substantial morbidity and mortality each year. Several herbal therapies were used for prevention and treatment viral respiratory illnesses. There is scientific evidence about several complementary health practices for colds. Zinc taken orally (by mouth) may reduce the length and severity of a cold. For most people, taking vitamin C supplements on a regular basis only slightly reduces the length and severity of colds and does not reduce the number of colds that they catch. Probiotics were found better than placebo in reducing the number of participants experiencing episodes of acute URTIs, the rate ratio of episodes of acute URTI and reducing antibiotic use. This indicates that probiotics may be more beneficial than placebo for preventing acute URTIs. Diarrhea associated with rotavirus is one of the major gastrointestinal problems faced by human infants. The protective effectiveness of probiotic feeding against naturally acquired diarrhea is also under investigation. Alkanization of blood by diet or naturally may prevent or cure influenza. Disintegration of influenza A, B and C virion appeared to depend on pH level of the medium. Diet and drinking water play important role in the pH level of blood. In a slightly alkaline environment viruses might be weakened or do not multiply efficiently. Immune function may work better in alkaline medium as well. Earthing is another natural anti-inflammatory and antioxidant source for human body. It is now accepted that an overwhelming inflammatory response is the cause of human deaths from avian H5N1 influenza infection. Earthing accelerated immune response following vaccination, as demonstrated by increases of gamma globulin concentration.
About the issue
The scope of topics covered in the this issue include:
Submission Deadline: December 31, 2015Notification of Acceptance: January 31, 2016Final Version Due: February, 2016Special Issue Publishing Date: March, 2016
Chief Guest Editor
Haider Abdul-Lateef MousaCollege of Medicine, University of Basrah, IraqEmail: firstname.lastname@example.org
Submit your article now
Manuscripts should be submitted as an attached file to an e-mail directed to the Chief Guest Editor, Haider Abdul-Lateef Mousa at the address: <email@example.com>
or through the journal’s Paper Submission System.
Over the past decade, biomarker discovery has generated a huge impact in disease diagnosis, prognosis and therapy. The “Omics” storm has helped in the identification of many biomarkers of interest. Most of these biomarkers have clinical importance. This special issue will focus mainly on the identification and validation of gene or protein-based biomarker in human diseases and their clinical applications. Considering the huge burden of Infectious and non-communicable diseases worldwide, it becomes all the more essential to analyze the existing knowledge regarding the emerging role of disease biomarker and their subsequent impact in our society. Disease biomarker can not only play critical roles in clinical application but also in drug discovery and development. Taken together, this issue aims to publish articles related to biomarker discovery, their impact in controlling massive disease outbreaks as also biomarkers associated with early disease diagnosis and monitoring of disease severity as well as patient response to therapies and finally the evaluation of these biomarkers in clinical trials.
Submission Deadline: December 31, 2015Notification of Acceptance: February 29, 2016Final Version Due: March, 2016Special Issue Publishing Date: April, 2016
Dr. Sumi MukhopadhyayCalcutta School of Tropical Medicine, IndiaEmail: firstname.lastname@example.org
Guest EditorDr. Swarnali AcharyyaInstitute for Cancer Genetics, College of Physicians and Surgeons, Columbia University, New YorkEmail: email@example.com
Dr. Srikanta GoswamiNational Institute of Biomedical GenomicsEmail: firstname.lastname@example.org
Dr. Anil Kumar ChavaWalgreens, Henderson, KYEmail: email@example.com
Manuscripts should be submitted as an attached file to an e-mail directed to the Chief Guest Editor, Dr. Sumi Mukhopadhyay at the address: <firstname.lastname@example.org>
Ebola virus is the most dangerous of the five known viruses within the genus Ebolavirus. The Ebola outbreak in West Africa is the world's deadliest to date and the World Health Organization has declared an international health emergency as more than 2,100 people have died of the virus in Guinea, Liberia, Sierra Leone and Nigeria this year. Thus, the aim of this issue is to create public awareness by describing the basic features of the virus, its epidemiology and global response to Ebola outbreaks. Moreover, it will give readers a brief insight on the current strategies to diagnosis, treatment, and prevention of the disease. Therefore, this issue will be focused on the epidemiology and its global response to Ebola outbreaks, and current strategies to the diagnosis, treatment, prevention and control.
Submission Deadline: November 20, 2014Notification of Acceptance: December 10, 2014Final Version Due: December 30, 2014Special Issue Publishing Date: January, 2015
Tewelde TesfayeDepartment of Medical Microbiology and Immunology, Institute of Biomedical Sciences, College of Health Sciences, Mekelle University, EthiopiaEmail: email@example.com
Guest EditorDr. Araya Abrha MedhanyieDepartment of Public Health, Mekelle University, Mekelle, EthiopiaEmail: firstname.lastname@example.org
Dr. Mahmud Abdulkader MahmudDepartment of Medical Microbiology and Immunology, Institute of Biomedical Sciences, College of Health Sciences, Mekelle University, EthiopiaEmail: email@example.com
Manuscripts should be submitted as an attached file to an e-mail directed to the Chief Guest Editor, Tewelde Tesfaye at the address: <firstname.lastname@example.org>